These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29567426)

  • 1. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
    Geng L; Zhang T; Liu W; Chen Y
    Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.
    Song Y; Liu Y; Chen X
    Yonsei Med J; 2018 May; 59(3):416-424. PubMed ID: 29611404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNHG1 promotes MPP
    Zhao J; Geng L; Chen Y; Wu C
    Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of BDNF production by MPP
    Zhang S; Chen S; Liu A; Wan J; Tang L; Zheng N; Xiong Y
    Neurosci Lett; 2018 May; 675():133-139. PubMed ID: 29030221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-124-3p attenuates MPP
    Geng L; Liu W; Chen Y
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1757-1764. PubMed ID: 28958159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease.
    Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y
    Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhai K; Liu B; Gao L
    Hum Gene Ther; 2020 Dec; 31(23-24):1274-1287. PubMed ID: 32808542
    [No Abstract]   [Full Text] [Related]  

  • 8. miR-9-5p modulates the progression of Parkinson's disease by targeting SIRT1.
    Wang Z; Sun L; Jia K; Wang H; Wang X
    Neurosci Lett; 2019 May; 701():226-233. PubMed ID: 30826419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA BACE1-antisense transcript plays a critical role in Parkinson's disease via microRNA-214-3p/Cell death-inducing p53-target protein 1 axis.
    Li L; Wang H; Li H; Lu X; Gao Y; Guo X
    Bioengineered; 2022 Apr; 13(4):10889-10901. PubMed ID: 35481549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease.
    Xu F; Bian N; Li X
    Neurochem Res; 2024 May; 49(5):1212-1225. PubMed ID: 38381247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA-p21 regulates MPP
    Ding XM; Zhao LJ; Qiao HY; Wu SL; Wang XH
    Chem Biol Interact; 2019 Jul; 307():73-81. PubMed ID: 31004593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models.
    Tao X; Zhang W; Chen C; Tao Y; Tao Y; Chen Z; Zhang G
    Aging (Albany NY); 2024 May; 16(10):8732-8746. PubMed ID: 38775730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-217/138-5p downregulation inhibits inflammatory response, oxidative stress and the induction of neuronal apoptosis in MPP
    Wang M; Sun H; Yao Y; Tang X; Wu B
    Am J Transl Res; 2019; 11(10):6619-6631. PubMed ID: 31737212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of long non-coding RNA AL049437 mitigates MPP+ -induced neuronal injury in SH-SY5Y cells via the microRNA-205-5p/MAPK1 axis.
    Zhang L; Wang J; Liu Q; Xiao Z; Dai Q
    Neurotoxicology; 2020 May; 78():29-35. PubMed ID: 32057949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-103a-3p regulates mitophagy in Parkinson's disease through Parkin/Ambra1 signaling.
    Zhou J; Zhao Y; Li Z; Zhu M; Wang Z; Li Y; Xu T; Feng D; Zhang S; Tang F; Yao J
    Pharmacol Res; 2020 Oct; 160():105197. PubMed ID: 32942015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway.
    Ren Y; Ye D; Ding Y; Wei N
    Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
    Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
    Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson's disease.
    Chen MY; Fan K; Zhao LJ; Wei JM; Gao JX; Li ZF
    Bioengineered; 2021 Dec; 12(1):708-719. PubMed ID: 33522352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SRY-box transcription factor 2 overlapping transcript participates in Parkinson's disease by regulating the microRNA-942-5p/nuclear apoptosis-inducing factor 1 axis.
    Guo Y; Liu Y; Wang H; Liu P
    Bioengineered; 2021 Dec; 12(1):8570-8582. PubMed ID: 34607512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.